Companies / Mustang Bio, Inc.

Mustang Bio, Inc.

Nasdaq: MBIOCIK 1680048WALTHAM, MA

Financials · FY2019

Revenue$0
Net income$-1.92M
Total debt$0
Cash$15.15M
Diluted EPS$-0.39
Shares outstanding7.6M

Ownership

7.6M shares outstanding · as of Aug 3, 2026
7.1%10%+ / strategic
Ownership
88.8%Class M
Share classes
Class M88.84%
Class A11.16%
10%+ / strategic7.08%536,577
Institutions7.78%589,193
Public float85.14%6,451,736

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 1

View all →
Insider% of sharesShares
Fortress Biotech, Inc.10% owner
7.08%536,577

Institutional holders 25

View all →
HolderValue% of shares
Kestra Advisory Services, LLC$108.9K1.47%
Citadel Advisors LLC$83.2K1.12%
DRW Securities, LLC$72.5K0.98%
Geode Capital Management, LLC$67.5K1.22%
BlackRock, Inc.$59.5K1.12%
Vanguard Group Inc$56.8K0.76%
XTX Topco Ltd$23.6K0.32%
Jane Street Group, LLC$13.9K0.19%
CFO4Life Group, LLC$12.7K0.17%
Two Sigma Investments, LP$12.2K0.22%

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Geode Capital Management, LLC
13F manager
AddCommon Stock$44.0K+61K
+187.41%
92,790
1.22% of shares
low
Q1 2026
as of
Two Sigma Investments, LP
13F manager
TrimCommon Stock$-16.9K-23K
-58.15%
16,754
0.22% of shares
low
Q1 2026
as of
Gsa Capital Partners LLP
13F manager
ExitCommon Stock$-13-13K
-100.00%
0
low
Q4 2025
as of
Danske Bank A/S
13F manager
NewCommon Stock$2+2
2
<0.01% of shares
low
Q4 2025
as of
Bank of America Corp /De
13F manager
AddCommon Stock$2+2
+3.85%
54
<0.01% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
MBIOCommon StockEquity62818Q302BBG00FXTN420